COVLIAS 1.0 vs. MedSeg: Artificial Intelligence-Based Comparative Study for Automated COVID-19 Computed Tomography Lung Segmentation in Italian and Croatian Cohorts
Jasjit S. Suri,
Sushant Agarwal,
Alessandro Carriero,
Alessio Paschè,
Pietro S. C. Danna,
Marta Columbu,
Luca Saba,
Klaudija Viskovic,
Armin Mehmedović,
Samriddhi Agarwal,
Lakshya Gupta,
Gavino Faa,
Inder M. Singh,
Monika Turk,
Paramjit S. Chadha,
Amer M. Johri,
Narendra N. Khanna,
Sophie Mavrogeni,
John R. Laird,
Gyan Pareek,
Martin Miner,
David W. Sobel,
Antonella Balestrieri,
Petros P. Sfikakis,
George Tsoulfas,
Athanasios Protogerou,
Durga Prasanna Misra,
Vikas Agarwal,
George D. Kitas,
Jagjit S. Teji,
Mustafa Al-Maini,
Surinder K. Dhanjil,
Andrew Nicolaides,
Aditya Sharma,
Vijay Rathore,
Mostafa Fatemi,
Azra Alizad,
Pudukode R. Krishnan,
Ferenc Nagy,
Zoltan Ruzsa,
Archna Gupta,
Subbaram Naidu,
Kosmas I. Paraskevas,
Mannudeep K. Kalra
Affiliations
Jasjit S. Suri
Stroke Diagnostic and Monitoring Division, AtheroPoint™, Roseville, CA 95661, USA
Sushant Agarwal
Advanced Knowledge Engineering Centre, Global Biomedical Technologies, Inc., Roseville, CA 95661, USA
Alessandro Carriero
Department of Radiology, “Maggiore della Carità” Hospital, University of Piemonte Orientale (UPO), 28100 Novara, Italy
Alessio Paschè
Department of Radiology, Azienda Ospedaliero Universitaria (A.O.U.), 09124 Cagliari, Italy
Pietro S. C. Danna
Department of Radiology, Azienda Ospedaliero Universitaria (A.O.U.), 09124 Cagliari, Italy
Marta Columbu
Department of Radiology, Azienda Ospedaliero Universitaria (A.O.U.), 09124 Cagliari, Italy
Luca Saba
Department of Radiology, Azienda Ospedaliero Universitaria (A.O.U.), 09124 Cagliari, Italy
Klaudija Viskovic
Department of Radiology and Ultrasound, University Hospital for Infectious Diseases, 10 000 Zagreb, Croatia
Armin Mehmedović
Department of Radiology and Ultrasound, University Hospital for Infectious Diseases, 10 000 Zagreb, Croatia
Samriddhi Agarwal
Advanced Knowledge Engineering Centre, Global Biomedical Technologies, Inc., Roseville, CA 95661, USA
Lakshya Gupta
Advanced Knowledge Engineering Centre, Global Biomedical Technologies, Inc., Roseville, CA 95661, USA
Gavino Faa
Department of Pathology, AOU of Cagliari, 09124 Cagliari, Italy
Inder M. Singh
Stroke Diagnostic and Monitoring Division, AtheroPoint™, Roseville, CA 95661, USA
Monika Turk
The Hanse-Wissenschaftskolleg Institute for Advanced Study, 27753 Delmenhorst, Germany
Paramjit S. Chadha
Stroke Diagnostic and Monitoring Division, AtheroPoint™, Roseville, CA 95661, USA
Amer M. Johri
Department of Medicine, Division of Cardiology, Queen’s University, Kingston, ON K7L 3N6, Canada
Narendra N. Khanna
Department of Cardiology, Indraprastha APOLLO Hospitals, New Delhi 110076, India
Sophie Mavrogeni
Cardiology Clinic, Onassis Cardiac Surgery Center, 17674 Athens, Greece
John R. Laird
Heart and Vascular Institute, Adventist Health St. Helena, St Helena, CA 94574, USA
Gyan Pareek
Minimally Invasive Urology Institute, Brown University, Providence, RI 02912, USA
Martin Miner
Men’s Health Center, Miriam Hospital, Providence, RI 02906, USA
David W. Sobel
Minimally Invasive Urology Institute, Brown University, Providence, RI 02912, USA
Antonella Balestrieri
Department of Radiology, Azienda Ospedaliero Universitaria (A.O.U.), 09124 Cagliari, Italy
Petros P. Sfikakis
Rheumatology Unit, National Kapodistrian University of Athens, 15772 Athens, Greece
George Tsoulfas
Department of Surgery, Aristoteleion University of Thessaloniki, 54124 Thessaloniki, Greece
Athanasios Protogerou
Cardiovascular Prevention and Research Unit, Department of Pathophysiology, National & Kapodistrian University of Athens, 15772 Athens, Greece
Durga Prasanna Misra
Department of Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow 226014, India
Vikas Agarwal
Department of Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow 226014, India
George D. Kitas
Academic Affairs, Dudley Group NHS Foundation Trust, Dudley DY1 2HQ, UK
Jagjit S. Teji
Ann and Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL 60611, USA
Mustafa Al-Maini
Allergy, Clinical Immunology and Rheumatology Institute, Toronto, ON L4Z 4C4, Canada
Surinder K. Dhanjil
AtheroPoint LLC, Roseville, CA 95611, USA
Andrew Nicolaides
Vascular Screening and Diagnostic Centre and University of Nicosia Medical School, Nicosia 2408, Cyprus
Aditya Sharma
Division of Cardiovascular Medicine, University of Virginia, Charlottesville, VA 22904, USA
Vijay Rathore
AtheroPoint LLC, Roseville, CA 95611, USA
Mostafa Fatemi
Department of Physiology & Biomedical Engg., Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA
Azra Alizad
Department of Radiology, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA
Pudukode R. Krishnan
Neurology Department, Fortis Hospital, Bangalore 560076, India
Ferenc Nagy
Internal Medicine Department, University of Szeged, 6725 Szeged, Hungary
Zoltan Ruzsa
Invasive Cardiology Division, University of Szeged, 6725 Szeged, Hungary
Archna Gupta
Radiology Department, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow 226014, India
Subbaram Naidu
Electrical Engineering Department, University of Minnesota, Duluth, MN 55812, USA
Kosmas I. Paraskevas
Department of Vascular Surgery, Central Clinic of Athens, 14122 Athens, Greece
Mannudeep K. Kalra
Department of Radiology, Massachusetts General Hospital, Boston, MA 02114, USA
(1) Background: COVID-19 computed tomography (CT) lung segmentation is critical for COVID lung severity diagnosis. Earlier proposed approaches during 2020–2021 were semiautomated or automated but not accurate, user-friendly, and industry-standard benchmarked. The proposed study compared the COVID Lung Image Analysis System, COVLIAS 1.0 (GBTI, Inc., and AtheroPointTM, Roseville, CA, USA, referred to as COVLIAS), against MedSeg, a web-based Artificial Intelligence (AI) segmentation tool, where COVLIAS uses hybrid deep learning (HDL) models for CT lung segmentation. (2) Materials and Methods: The proposed study used 5000 ITALIAN COVID-19 positive CT lung images collected from 72 patients (experimental data) that confirmed the reverse transcription-polymerase chain reaction (RT-PCR) test. Two hybrid AI models from the COVLIAS system, namely, VGG-SegNet (HDL 1) and ResNet-SegNet (HDL 2), were used to segment the CT lungs. As part of the results, we compared both COVLIAS and MedSeg against two manual delineations (MD 1 and MD 2) using (i) Bland–Altman plots, (ii) Correlation coefficient (CC) plots, (iii) Receiver operating characteristic curve, and (iv) Figure of Merit and (v) visual overlays. A cohort of 500 CROATIA COVID-19 positive CT lung images (validation data) was used. A previously trained COVLIAS model was directly applied to the validation data (as part of Unseen-AI) to segment the CT lungs and compare them against MedSeg. (3) Result: For the experimental data, the four CCs between COVLIAS (HDL 1) vs. MD 1, COVLIAS (HDL 1) vs. MD 2, COVLIAS (HDL 2) vs. MD 1, and COVLIAS (HDL 2) vs. MD 2 were 0.96, 0.96, 0.96, and 0.96, respectively. The mean value of the COVLIAS system for the above four readings was 0.96. CC between MedSeg vs. MD 1 and MedSeg vs. MD 2 was 0.98 and 0.98, respectively. Both had a mean value of 0.98. On the validation data, the CC between COVLIAS (HDL 1) vs. MedSeg and COVLIAS (HDL 2) vs. MedSeg was 0.98 and 0.99, respectively. For the experimental data, the difference between the mean values for COVLIAS and MedSeg showed a difference of <2.5%, meeting the standard of equivalence. The average running times for COVLIAS and MedSeg on a single lung CT slice were ~4 s and ~10 s, respectively. (4) Conclusions: The performances of COVLIAS and MedSeg were similar. However, COVLIAS showed improved computing time over MedSeg.